CPhI Podcast Series podcast

What does the changing US Pharma market mean for industry and patients alike?

Spol 15 sekunder tilbage
Spol 15 sekunder frem

This episode covers the recent changes in legislature around drug pricing in the USA, and what this means for the global pharma market, as well as the impact it will have on the US population in terms of access to medicine. The price negotiations with Medicare are targeting medications used in the treatment of many chronic diseases such as cardiovascular disease and diabetes. We will take a look at what this means for people with chronic disease, and conversely the impact on the individual pharma companies and then more widely, on innovation in the industry.

Flere episoder fra "CPhI Podcast Series"